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Bahram Sohrabi, MD,* Peiman Jamshidi, MD,*y Alireza Yaghoubi, MD,*
Afshin Habibzadeh, MD,* Yashar Hashemi-aghdam, MD,z Araz Moin, MD,z
Babak Kazemi, MD,* Samad Ghaffari, MD,* Mohammad Reza Abdolahzadeh Baghayi, MD,*
Khalil Mahmoody, MDx
Tabriz and Zanjan, Iran; and Lucerne, SwitzerlandObjectives This study sought to evaluate the outcomes of endovascular treatment with covered
versus bare Cheatham-platinum stents (NuMed, Hopkinton, New York) in coarctation of aorta (CoA)
patients.
Background Covered stenting has been newly recognized as a useful therapeutic method for patients
with native CoA, but there has been no study comparing the use of covered stents with bare stents for
treating CoA.
Methods In this randomized clinical trial, 120 patients with a mean age of 23.60  10.99 years (range
12 to 58 years, 79 men), with post-ductal, short-segment, severe native CoA underwent implantation of
bare Cheatham-Platinum (bCP) (n ¼ 60) or covered Cheatham-Platinum (cCP) (n ¼ 60) stents. Patients
were followed clinically at 1, 3, 6, and 12 months after the stenting and yearly thereafter. During
follow-up, multislice computed tomography (64 slices) was scheduled to assess any complications.
Results The procedural success rate was 100% in both groups. Patients were followed for 31.1 
19.2 months. Although recoarctation was seen only in the bCP group during follow-up, the difference
between groups did not reach statistical signiﬁcance (6.7% vs. 0%; p¼ NS). Two cases of pseudoaneurysm
(3.3%) occurred in the cCP group, but none was observed in the bCP group (p ¼ NS). Normotensive
status signiﬁcantly increased during follow-up in both groups (from 15% to 73.3% in the bCP group
and 16.7% to 78.3% in the cCP group, p < 0.001 for each group and not signiﬁcant between groups).
Conclusions Implanting bCP and cCP stents have very high success rates with remarkable
hemodynamic effects in severe native CoA patients. Patients undergoing cCP stent implantation
experienced a nonsigniﬁcantly lower recoarctation rate and a higher occurrence of pseudoaneurysm
formation with respect to bCP stenting during follow-up. These ﬁndings indicate that CoA stenting
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417Coarctation of the aorta (CoA) is a congenital cardiovascular
malformation with relatively low prevalence and is charac-
terized by a narrowing of the thoracic aorta mostly just distal
to the left subclavian artery (1,2). CoA is normally detected
and repaired surgically in childhood, but it occasionally re-
curs or presents de novo in adolescence or adulthood. If left
untreated in childhood, CoA has a poor prognosis due to
complications such as aneurysms, dissections, coronary ar-
tery disease, and intracranial hemorrhage. These complica-
tions mostly result from arterial hypertension secondary to
the coarctation, and most patients die before reaching the
age of 50 years from stroke, coronary heart disease, or sud-
den death (1–3).See page 424
Abbreviations
and Acronyms
bCP = bare Cheatham-
Platinum stent
BP = blood pressure
cCP = covered Cheatham-
Platinum stent
CoA = coarctation of the
aorta
CT = computed tomographyIt has been documented that surgery, balloon dilation, and
stent implantation are effective in the treatment of CoA in
adults (4–6). Bare stent implantation in the treatment for native
and recurrent CoA has become an excellent alternative to sur-
gery and balloon angioplasty with better results (7–12).
Although bare stents have considerable results, they are asso-
ciated with some signiﬁcant complications including aortic
rupture, dissection, aneurysm formation, and even death (12–
16). In such complicated patients, implanting a covered stent is
commonly used as a rescue treatment.
Covered stents are widely used in the treatment of
atherosclerotic abdominal and thoracic aneurysms in adults
(17). There are limited data in the literature about the use
of covered stents in patients with aortic coarctation (4,16,18–
22) (Table 1), and there is no study comparing between
covered and bare stents in this regard. We aimed to compare
the immediate and intermediate-term outcomes of endo-
vascular stenting with bare Cheatham-Platinum (bCP)
versus covered Cheatham-Platinum stents (cCP) (NuMed,
Hopkinton, New York) to ﬁnd the best treatment method in
patients with native CoA.Methods
In this randomized clinical trial, 120 patients with post-
ductal, short-segment, near atretic, native CoA underwent
treatment with bCP or cCP stent implantation between
September 1, 2007, and February 1, 2011 at Madani Heart
Center, the largest tertiary cardiac center in North West of
Iran. CoA was deﬁned as the presence of systemic hyper-
tension with an upper- to lower-limb systolic blood
pressure (BP) difference 20 mm Hg, which was
conﬁrmed by echocardiography, computed tomography
(CT) angiography, or aortography. We enrolled only pa-
tients with native coarctation and those with recoarctation.
Patients with long segmental coarctation, hypoplasia of
aortic arch, or pre-ductal coarctation were excluded from thestudy. Also patients under 10 years of age or those with a
body weights <30 kg were excluded from the study.
Patients, who met the inclusion criteria, were randomly
assigned to either the bCP or cCP groups. Computer-
assisted randomization was performed. Numbered, sealed
envelopes that contained the study group assignment were
distributed among the subjects and were opened after
informed, written consent had been obtained prior to the
procedure. The study protocol was approved by the Ethics
Committee of Tabriz University of Medical Sciences.
Study protocol. After randomization, all patients underwent
stenting for CoA. All procedures were performed by 2 expe-
rienced interventionists under general anesthesia and ﬂuoro-
scopic guidance in the cardiac catheterization laboratory.
Heparin sulfate (100 IU/kg; maximum, 10,000 IU) was
given intravenously, after right femoral artery access was
obtained and a 5-F sheath was inserted. Intravenous cefa-
zolin (20 mg/kg) was also given during the procedure and at
6-h intervals (total of 6 doses). The lesion was crossed in
a retrograde manner using a 5-F right coronary Judkins
catheter (Cordis Corporation, Miami, Florida) with the aid
of a ﬂexible-tip guidewire, 0.035
inches in diameter. Standard left
heart catheterization was carried
out, and aortograms were taken
in left lateral, left anterior obli-
que, and shallow right anterior
oblique with mild caudal angu-
lation views to best proﬁle the
lesion (Fig. 1). To help crossing
the coarctation segment and for
proper stent deployment, we
used the radial approach in
difﬁcult cases. The ﬁrst wire was exchanged for an Amplatz
super-stiff, 0.035-inch, 260-cm wire (Cook Cardiology,
Bloomington, Indiana), which was left in the right brachial
artery, enabling the straightest course for subsequent stent
deployment. Pre-dilation with a small balloon was strongly
prohibited.
In all procedures, Cheatham-Platinum stents were used for
both the covered and bare stents. The Cheatham-Platinum
stent was hand-crimped down onto a balloon-in-balloon
catheter (NuMed), which allows a precise and safe stent de-
livery.We used 12-F blue long sheaths (CookCardiology) for
bCP stent and 14-F sheaths for cCP stent delivery. The
balloon diameter was selected based on the proximal isthmus
at the level of takeoff of the left subclavian artery, not
exceeding the diameter of the aorta at the level of the dia-
phragm. The length of the chosen stent was based on the
distance between the left subclavian artery and 15mm beyond
the site of the CoA. After proper balloon size selection, im-
mediate full dilation of the stent beyond its nominal pressure
was performed in 1 step to achieve complete or near complete
disappearance of the waist. Hemodynamic data and
Table 1. Studies Published on Stenting of CoA
First Author (Ref. #) Year n Indications
Procedure
Success Rate, %
Mean Age,
yrs (Range)
Mean Follow-Up,
Months (Range) Stent(s)*
Pedra et al. (18) 2005 9 Severe native CoA
Age >50 yrs
Associated PDA
Fracture within a previously
implanted stent
100 31 (8–57) 12 s CP stent
Braile stent
Tzifa et al. (16) 2006 30 CoA associated with
aneurysms or previous
stent-related complications
Complex CoA anatomy
Advanced age
100 28 (8–65) 11 (0–40) CP stent
Kenny et al. (19) 2006 37 Native CoA
Recurrent CoA following
surgical treatment
Aneurysm following
previous CoA surgery
Aortobronchial ﬁstula
Stent fracture
Associated PDA
97.29 29.6 (9–65) 11.5 (1–56) CP stent
Valiant stent graft
Jostent stent graft
Palmaz Genesis
covered stent
Butera et al. (20) 2007 33 Complex CoA anatomy 100 13 (6–66) 12 (1–40) CP stent
Tanous et al. (4) 2010 22 Native CoA
Recurrent CoA or
aneurysm following
previous surgical repair
100 39 (19–67) 12 (9–15) CP stent
Bruckheimer et al. (21) 2009 22 Native CoA 100 15.5 (7.8–38.6) 18.5 (1.6–31.4) CP stent
Chang et al. (22) 2012 25 Native CoA
Associated PDA
100 22.5 (14–44) 72 CP stent
*1. CP stent (NuMED, Nicholville, New York); 2. Braile stent (Braile Biomedica, SJ Rio Preto, Sao Paulo, Brazil); 3. Valiant Thoracic Stent Graft (Medtronic Endovascular, Santa Rosa, California); 4. Jostent stent-
graft (Jomed GmbH, Rangendingen, Germany); 5. Palmaz-Genesis stent (Cordis / Johnson and Johnson). There is no previous study comparing bare and covered CP stents, and we have only included
studies with CP stents, mostly covered CP stents.
CoA ¼ coarctation of aorta; CP ¼ Cheatham-Platinum; PDA ¼ patent ductus arteriosus.
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418angiographic measurements of the coarctation segment and
other proﬁles were measured. A successful outcome was
deﬁned as a peak systolic pressure gradient after stent im-
plantation of <15 mm Hg at the site of coarctation with
no evidence of stent migration or aortic dissection. Hemo-
stasis was achieved by manual compression. On discharge,
aspirin 100 mg/day was prescribed for all patients for up to
6 months. Access site injury was assessed clinically immedi-
ately after the procedure and during follow-up.
Patients were followed at 1, 3, 6, and 12 months after
stenting and yearly thereafter. Mean follow-up duration was
31.1  19.2 months (range 12 to 60) months. During
the follow-up, patients underwent physical examination
including BP measurements and echocardiography. The
routine chest x-ray, which was done on every follow-up visit,
happened to be fairly useful in detecting stent migration. A
multislice computed tomography (64 slices) was scheduled
after 6 months to assess possible intimal hyperplasia, stent
position, diameter at the dilated site, and the presence of an
aneurysm (deﬁned as >3 mm bulging) (Fig. 2). Routine
survey for stent fractures was not done.
Our primary endpoint was recoarctation after the proce-
dure, which was deﬁned on the basis of a combination
of clinical signs (arm-leg BP difference >20 mm Hg)and noninvasive imaging by echocardiography (gradient
>20 mm Hg) or invasive gradient measurements by cathe-
terization and >10% of the stent lumen obstruction due to
intimal proliferation within the stent. Secondary endpoints
were mortality, pseudoaneurysm, obstruction of left subcla-
vian artery, aortic dissection, migration of stent during
procedure, post-CoA syndrome, hypertension, and need
for antihypertensive drugs during follow-up period. Anti-
hypertensive medications were discontinued or reduced, if
possible, at the referring physician’s discretion.
Statistical analysis. Statistical analyses were performed us-
ing the Statistical Package for Social Sciences (version 16.0,
SPSS Inc., Chicago, Illinois). Quantitative data were pre-
sented as mean  SD, and qualitative data were dem-
onstrated as frequency (percentage). The categorical
parameters were compared by chi-square or 2-tailed Fisher
exact tests when applicable, and the continuous variables
were compared by Student t test for independent continuous
scale data and Mann-Whitney U test for nonparametric data
when appropriate. To compare values before and after the
procedure, paired samples t tests for continuous variables
and McNemar tests for categorical parameters were used.
Repeated measure of analysis of variance was used to
compare mean diastolic and mean systolic BP changes
Figure 1. Baseline Descending Aortogram
Baseline descending aortogram in lateral view with pigtail catheter showing
severe coarctation.
Figure 2. Multislice CT Angiography (64 Slices) During 8-Month Follow-Up
in a Patient Who Underwent Covered CP Stent Implantation
Volume rendering techniques show good positioning of the stent without any
complication. CP ¼ Cheatham-Platinum; CT ¼ computed tomography.
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419during the study in each group and between groups. A
p value <0.05 was considered signiﬁcant.Table 3. Angiographic and Stent Characteristics in Covered and
Bare Stent Groups
Bare CP
(n ¼ 60)
Covered CP
(n ¼ 60) p ValueResults
During this study, 120 patients with a mean age of 23.60 
10.99 years (range 12 to 58 years; 79 men) underwent bCP
(n ¼ 60) and cCP (n ¼ 60) stent implantation. Patients
in both groups were matched for baseline characteristics
(Table 2). There was no signiﬁcant difference between
groups in angiographic ﬁndings and stent characteristics
(Table 3). The procedures were successful in all patients in
both groups without any malposition, migration, or dissec-
tion. In 20 cases, a radial approach was required to cross theTable 2. Baseline Characteristics in Covered and Bare Stent Groups
Bare CP
(n ¼ 60)
Covered CP
(n ¼ 60) p Value
Age, yrs 24.66  13.03 22.55  8.48 NS
Male 40 (66.7) 40 (66.7) NS
Associated cardiac ﬁndings 39 (65.0) 40 (66.7) NS
Cardiac complication of
aortic valve
12 (20.0) 27 (47.4)
Coronary artery disease 2 (3.3) 1 (1.8)
Aortic stenosis 5 (8.3) 3 (5.3)
Aortic insufﬁciency 14 (23.3) 8 (14)
Ventricular septal defect
with/without repair
6 (10) 1 (1.8)
Values are mean  SD or n (%).
CP ¼ Cheatham-Platinum; NS ¼ not signiﬁcant.stenotic segment, and after crossing and snaring the wire,
the procedure was continued through the femoral approach.
Overall, the CoA diameter increased from 3.32 
0.65 mm to 15.94  2.23 mm (p < 0.001) and the pres-
sure gradient across the CoA site decreased from 54.6 
14.5 mm Hg to 3.38  1.61 mm Hg (p < 0.001). There
was no incidence of paraplegia, bleeding, vascularMean systolic gradient before
procedure, mm Hg
54.61  15.05 54.42  12.04 NS
Mean systolic gradient after
procedure, mm Hg
3.47  1.68 3.36  1.65 NS
Mean length of coarctation, mm 16.52  3.92 16.61  3.31 NS
Mean diameter of coarctation
segment before procedure, mm
3.34  0.59 3.30  0.70 NS
Mean diameter of coarctation
segment after procedure, mm
16.07  1.88 15.82  2.51 NS
Mean diameter of diaphragmatic
aorta, mm
16.71  1.34 16.88  1.80 NS
Mean diameter of the aorta after
left subclavian artery, mm
16.64  1.15 16.88  1.72 NS
Mean length of the stent, mm 30.31  7.24 28.94  8.75 NS
Mean diameter of the stent, mm 16.56  1.88 16.64  1.89 NS
Values are mean  SD.
Abbreviations as in Table 2.
Sohrabi et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 7 , N O . 4 , 2 0 1 4
Covered and Bare CP Stents for Post-Ductal CoA A P R I L 2 0 1 4 : 4 1 6 – 2 3
420complication, post-CoA syndrome, or death during the
procedure.
Mean systolic and diastolic BP were signiﬁcantly reduced in
both groups immediately after the procedure and at 1 month,
3 months, and the end of follow-up from values before
intervention (p < 0.001) (Fig. 3). There were no signiﬁcant
differences between groups in the mean systolic and diastolic
BP values before and during the follow-up period (p ¼ NS).
Overall, 101 (84.16%) patients (51 in the bCP and 50
in the cCP group) were on antihypertensive medications
before intervention; this was signiﬁcantly reduced to 29
(24.16%) patients (16 in the bCP and 13 in the cCP group)
during the follow-up (p < 0.001). There was no signiﬁcant
difference between bCP and cCP in normotensive patients
before (15% vs. 16.7%) and after (73.3% vs. 78.3%) inter-
vention (p ¼ NS); however, in both groups, it wasFigure 3. Signiﬁcant Reduction in Mean SBP and DBP Immediately After
the Procedure and at 1 and 3 Months and at the End of the Follow-Up
Signiﬁcant reduction in mean systolic blood pressure (SBP) (A) and diastolic
blood pressure (DBP) (B) immediately after and at 1 month, 3 months, and
end of the follow-up period is shown. There is no signiﬁcant difference
between treatment groups.signiﬁcantly increased during follow-up (both p < 0.001).
At the last assessment session, 6 patients continued their
antihypertensive drugs with the same dosage; the dosage was
reduced in 24 and discontinued in 50 patients due to the
normalization of the BP.
There was no difference between groups in duration of
hospitalization (3.44  2.41 days in the bCP group vs. 3.05
 0.93 days in the cCP group; p ¼ NS). Table 4 demon-
strates the clinical ﬁndings during the follow-up in both
groups. Occurrence of recoarctation was seen only in the
bCP group during follow-up, but the difference between
groups with respect to this complication was not statistically
signiﬁcant (6.7% vs. 0%; p ¼ NS). The recoarctation cases
included 2 female and 2 male patients (ages 12, 15, 30, and
48 years). All recoarctation cases occurred between 6 and 12
months after stent implantation. They were treated
with covered stents and had no recurrence or complications
during follow-up.
Although more pseudoaneurysm formation was seen with
cCP stenting (0% vs. 3.3%), the difference between groups
was not signiﬁcant (Table 4). Pseudoaneurysms occurred in
the 12- and 21-year-old patients, 30 and 40 days after initial
stenting (Fig. 4). The presentation of both of these pati-
ents was severe back pain, and immediate CT angiography
showed pseudoaneurysm formation just proximal to the
implanted covered stent. Re-evaluation of the ﬁrst procedure
revealed prolonged and multiple attempts with different
kinds of guidewires including Terumo hydrophilic wires, in
both patients. The pseudoaneurysms were treated success-
fully with another cCP stent implantation along the previous
stent. They had no other complaints during the follow-up.
Only 1 patient died during follow-up (Table 4), which
was a 20-year-old woman in the bCP stent group, and her
death was not related to the procedure. The patient became
pregnant during follow-up and had successful delivery
12 months after initial stenting. The death occurred
3 months after delivery because of severe heart failure due
to peripartum cardiomyopathy.
Our patients comprised 51 adolescents (18 years of age)
and 69 adults (>18 years of age). Comparing the clinical
ﬁndings during the follow-up between the adolescents and
adults (Table 5), there were no signiﬁcant differences bet-
ween groups.Table 4. Clinical Findings During Follow-Up Between Groups
Bare CP
(n ¼ 60)
Covered CP
(n ¼ 60) p Value
Recurrent coarctation 4 (6.7) 0 (0) NS
Pseudoaneurysm in aortic segment
at 12-month follow-up
0 2 (3.3) NS
Total mortality 1 (1.7) 0 NS
Values are n (%).
Abbreviations as in Table 2.
Figure 4. Pseudoaneurysm Formation Just Proximal to the Stent
30 Days After Covered CP Stent Implantation
(A) At 30-day follow-up, a pseudoaneurysm had formed proximal to the
covered CP stent. (B) After implanting a second covered stent, the pseu-
doaneurysm was completely obliterated. CP ¼ Cheatham-Platinum.
Table 5. Clinical Findings During Follow-Up Between
Adolescents and Adults
Adolescents 18 yrs
(n ¼ 51)
Adults >18 yrs
(n ¼ 69) p Value
Recurrent coarctation 2 (3.9) 2 (2.9) NS
Pseudoaneurysm in aortic
segment at 12-month
follow-up
1 (2) 1 (1.4) NS
Total mortality 0 1 (1.4) NS
Values are n (%).
NS ¼ not signiﬁcant.
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421Discussion
The main ﬁndings of this study are that CP stent implan-
tation in severe native CoA patients is highly successful and
results in remarkable hemodynamic effects, with no signif-
icant complication during the procedure and hospitalization.
During follow-up, patients undergoing cCP stentimplantation experienced a nonsigniﬁcantly lower recoarc-
tation rate and a higher occurrence of pseudoaneurysm
formation with respect to bCP stenting. In both groups, BP
was signiﬁcantly reduced after intervention.
Most available reports have evaluated only the outcome of
cCP stents or overall CP stents with small numbers of pa-
tients, and no comparison has been made between bCP and
cCP stents. To the best of our knowledge, this study is the
ﬁrst randomized clinical trial in a relatively large patient
population with CoA comparing these 2 types of stents. In
the technical point of view, performing the procedure in a
high-volume referral center, use of CP stents and balloon-
in-balloon catheter without pre-dilation, concurrent femoral
and radial approaches, and wire positioning in right sub-
clavian artery could be the reasons for the high success rate
with no periprocedural complications in our study.
For the evaluation of late complications such as aneurysm
formation and recoarctation, patients should be followed by
magnetic resonance angiography or CT. In our study, all
patients underwent 64-slice CT angiography for anatomic
evaluation of stented and peristented segments. During the
follow-up period, recoarctation occurred only in the bCP
group. Use of covered stents for complex and very severe
coarctations, especially in older patients with relatively less
compliant aortic walls, have been associated with encour-
aging results (11,23–25). Limited data are available on the
usefulness of covered stents in preventing recoarctation and
stenosis. Our study shows encouraging results with covered
stents for prevention of this complication in patients un-
dergoing endovascular treatment of native CoA. Although
recoarctation only occurred in the bCP group, the difference
between groups with regard to this complication was sta-
tistically nonsigniﬁcant. Most likely, increasing the sample
size of this study would have resulted in a signiﬁcant dif-
ference between groups on the occurrence of recoarctation.
In theory, the covered stent can protect the post-stenotic
area by redirecting the ﬂow away from the dilated areas and
more centrally into the descending aortic lumen. Never-
theless, no previous report has been issued on aneurysm or
pseudoaneurysm formation after covered stent placement.
However, we observed pseudoaneurysm formation in 2
patients in the cCP group, 30 and 40 days after initial
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422stenting just proximal to the stent; the pseudoaneurysms
were managed with implantation of another cCP stent
in both patients with no other complication during the
long-term follow-up. Re-evaluation of the ﬁrst procedure
revealed a severe coarctation segment with prolonged and
multiple attempts with different kinds of guidewires,
including Terumo hydrophilic wires, in both patients.
These frequent attempts to cross the subtotal segment may
traumatize the aortic wall and play a role in the occurrence
of this delayed major complication. It appears that Terumo
hydrophilic wires could easily pass to the subintima in severe
coarctation, leading to this delayed complication, and
should be used with extreme caution or not at all during the
procedure. We believe that in such cases with difﬁculties in
crossing the stenotic segment with hydrophilic wires and
higher probability of aortic wall trauma, implanting a
covered stent might be useful to reduce associated compli-
cations. This needs to be conﬁrmed in future larger multi-
center studies.
Some investigators propose to perform dilation and
coarctation stenting in 3 separate sessions with slow and
progressive dilation of the stent. However, our study showed
that the 1-step approach is highly successful and effective
and reduces the need for further admissions.
BP control can be improved in adult patients after relieving
the stenosis of coarctation (26). Like other studies (27), we
showed that the systolic gradient across the CoA and mean
systolic and diastolic BP were reduced after both types of CP
stent implantation. Our results are in accordance with others
(22,26) that implantation of the cCP stent is associated with
signiﬁcantly improved hemodynamic status and reduced
number of cases in need of antihypertensive medication.
Chang et al. (22) reported normotensive status after cCP stent
implantation in 84% of cases. In our study, normotensive
cases increased from 14% to 77.2% after procedure. These
ﬁndings are indicative of the effectiveness of covered stents on
improvement of patient’s hemodynamics.
Bare stent implantation also has a considerable effect
on hemodynamic status. In previous studies, it was accom-
panied by improvement in the systolic BP control and also
resulted in left ventricular mass reduction and improvement
in its long-axis function, which could reduce the incidence
of morbidity and mortality (4,28,29). In our study, pati-
ents with bare stent implantation also had signiﬁcant im-
provements in BP control after the procedure and during
follow-up (from 15% pre-intervention to 73.3% in the last
assessment).
In previous studies, reduction or discontinuation of anti-
hypertensive medication following stent implantation was
achieved in 18% to 88% of the patients (16,20,30–32).
Overall, in our study, antihypertensive therapy was reduced
or discontinued in 95.72% of the patients. However, the
improvement in hypertension control was not different be-
tween groups.As there were no in-hospital complications, patients were
discharged in a mean of 3 days after the procedure with no
difference between groups. In the study of Erdem et al. (33),
which evaluated 16 covered and 31 bCP stents, there was an
acute aortic wall rupture at the distal end of the implanted
bCP stent, which was successfully managed immediately in
the same session with the implantation of a second covered
stent. Also among cCP stents implanted in the study by
Tanous et al. (4), 1 patient required a second covered stent
for aortic wall rupture. It is notable that there is no report of
any procedure-related mortality in covered or bCP stenting
in the literature, whereas it is reported that death may occur
in 0% to 1.4% of cases after non-CP bare stenting (34). We
found no in-hospital complications in our study, which is in
favor of the safety of CP stent implantation in CoA patients.
Although in our study there was 1 death in a 20-year-old
female patient after bCP stenting, it was not related to the
procedure and occurred after pregnancy and was presumed
to be due to peripartum cardiomyopathy.
Study limitations. Although the ﬁrst randomized clinical
trial in this respect, our study was limited in some aspects.
First, during follow-up, patients did not undergo 24-h
ambulatory BP monitoring, which could have diagnosed the
normotensive state more accurately. Second, evaluation of
the BP response during exercise testing could have been
more valuable in deﬁning the procedure outcome.Conclusions
Implanting bCP and cCP stents have very high success
rates with remarkable hemodynamic effects in patients with
severe, native, post-ductal CoA. Patients undergoing cCP
stent implantation experience a nonsigniﬁcantly lower re-
coarctation rate and higher occurrence of pseudoaneurysm
formation with respect to bCP stenting during follow-up.
These ﬁndings indicate that CoA stenting is a safe proce-
dure. However, these ﬁndings may not be applicable to
other anatomical variants of coarctation.Acknowledgments
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